• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US 4.75 HEALIX ADVANCE KNTLSS BR; SOFT-TISSUE ANCHOR, BIOABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US 4.75 HEALIX ADVANCE KNTLSS BR; SOFT-TISSUE ANCHOR, BIOABSORBABLE Back to Search Results
Model Number 222330
Device Problems Loose or Intermittent Connection (1371); Migration or Expulsion of Device (1395)
Patient Problem Not Applicable (3189)
Event Date 04/08/2020
Event Type  malfunction  
Manufacturer Narrative
Product complaint #: (b)(4).Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Udi: (b)(4).
 
Event Description
It was reported by affiliate via personal interaction that during arthroscopic rotator cuff repair,the anchors (4.75 healix advance kntlss br, 4.5 healix advance br3sut w/oc) were used for the rotator cuff bridge technique but came off the bone.Finally, the procedure was completed with replacements less than 30-minute surgical delay.No fragment was left in the patient's body.There was no harm to the patient.The devices were the first use when the issue occurred.The surgeon commented that the bone quality was inferior.Additional information provided by the affiliate reported the device will not be returned for evaluation and additional detail pertaining the event are not available.
 
Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by mitek or its employees that the report constitutes an admission that the device, mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.H10 additional narrative: investigation summary: the complaint device is not being returned, therefore unavailable for a physical evaluation.With the information provided, and without the complaint device to evaluate, we cannot determine a root cause for the reported failure.A manufacturing record evaluation was performed for the finished device lot number (5l44955), and no non-conformances were identified.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
4.75 HEALIX ADVANCE KNTLSS BR
Type of Device
SOFT-TISSUE ANCHOR, BIOABSORBABLE
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
MDR Report Key10195868
MDR Text Key202701358
Report Number1221934-2020-01630
Device Sequence Number1
Product Code MAI
UDI-Device Identifier10886705023462
UDI-Public10886705023462
Combination Product (y/n)N
PMA/PMN Number
K130917
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup
Report Date 06/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2022
Device Model Number222330
Device Catalogue Number222330
Device Lot Number5L44955
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/09/2020
Initial Date FDA Received06/25/2020
Supplement Dates Manufacturer Received06/29/2020
Supplement Dates FDA Received06/29/2020
Patient Sequence Number1
-
-